• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Latest News

Bridging the Communication Gap Between Providers and Patients Through the Skin Quality Index
Bridging the Communication Gap Between Providers and Patients Through the Skin Quality Index

April 4th 2025

Allergan’s latest initiative hopes to empower both patients and clinicians while advancing industry standards, according to Sherket Peterson, PhD.

Patient Survey Highlights Dissatisfaction and Undertreatment in Hidradenitis Suppurativa Care
Patient Survey Highlights Dissatisfaction and Undertreatment in Hidradenitis Suppurativa Care

April 4th 2025

New Study Compares Infection Risk of AD Systemic Therapies
New Study Compares Infection Risk of AD Systemic Therapies

April 4th 2025

Allergan Aesthetics' Effort to Create a Unified Vocabulary for Skin Quality
Allergan Aesthetics' Effort to Create a Unified Vocabulary for Skin Quality

April 4th 2025

The Power of Art in Clinical Spaces
The Power of Art in Clinical Spaces

April 4th 2025

Register Now for Revolutionizing Atopic Dermatitis
Minimize Complications With Advanced Laser Techniques
Introducing Dermatology Times' 2025 Editor in Chief
Subscribe Now for Free - eNL
Explore Our Conference Coverage
Subscribe for Free - Print
Advancing AD Treatment: Expert-Led Case Discussions
Breaking Down New Treatment Options in Pediatric Atopic Dermatitis
Stay Informed!
Don't miss the latest in dermatology news
Resources Tailored for Dermatology Nurse Practitioners & Physician Assistants

Conference Coverage

View All
Exploring the 2025 Revolutionizing Atopic Dermatitis (RAD) Annual Meeting Agenda
Exploring the 2025 Revolutionizing Atopic Dermatitis (RAD) Annual Meeting Agenda

April 2nd 2025

Dermatology Conferences and Meetings Calendar: April 2025
Dermatology Conferences and Meetings Calendar: April 2025

April 1st 2025

“Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and Retinoids
“Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and Retinoids

March 24th 2025

A Walk Through The AAD 2025 Poster Hall: The Must-See Research Shaping Dermatology
A Walk Through The AAD 2025 Poster Hall: The Must-See Research Shaping Dermatology

March 18th 2025

Latest Videos
Safety Considerations for IL-17 Inhibitors
Safety Considerations for IL-17 Inhibitors
Selecting and Dosing IL-17 Inhibitors in Psoriasis
Selecting and Dosing IL-17 Inhibitors in Psoriasis
Key Takeaways on GEP Testing in Melanoma and SCC
Key Takeaways on GEP Testing in Melanoma and SCC
De-Escalating Treatment Plans With Gene Expression Profiling in an 80-Year-Old Man With SCC
De-Escalating Treatment Plans With Gene Expression Profiling in an 80-Year-Old Man With SCC
Switching from Biologics to JAK Inhibitors in Nonresponders and Dose Escalation
Switching from Biologics to JAK Inhibitors in Nonresponders and Dose Escalation
Balancing Education and Reassurance: Guiding Parents Through the Safety Profile of New Therapies
Balancing Education and Reassurance: Guiding Parents Through the Safety Profile of New Therapies
Essential Monitoring Considerations for Prescribing Topical JAK Inhibitors in Younger Children
Essential Monitoring Considerations for Prescribing Topical JAK Inhibitors in Younger Children
Evaluating the Safety of Topical JAK Inhibitors in the Pediatric Population: Insights into Systemic Risks and Adverse Effects
Evaluating the Safety of Topical JAK Inhibitors in the Pediatric Population: Insights into Systemic Risks and Adverse Effects
Overcoming Therapeutic Inertia in a 25-Year-Old Man with Moderate to Severe Atopic Dermatitis
Overcoming Therapeutic Inertia in a 25-Year-Old Man with Moderate to Severe Atopic Dermatitis
Safety Considerations in Pediatric Atopic Dermatitis Treatments
Safety Considerations in Pediatric Atopic Dermatitis Treatments
Melinda Gooderham, MD, MSc, FRCPC: Reaffirming Delgocitinib Safety With Minimal Absorption, Maximum Confidence
Melinda Gooderham, MD, MSc, FRCPC: Reaffirming Delgocitinib Safety With Minimal Absorption, Maximum Confidence
Quality of Life Impact: Supporting Patients With GPP
Quality of Life Impact: Supporting Patients With GPP
The Challenges of Diagnosis and Management of GPP
The Challenges of Diagnosis and Management of GPP
Melinda Gooderham, MD, MSc, FRCPC: Minimal Systemic Exposure of Delgocitinib Cream in Chronic Hand Eczema
Melinda Gooderham, MD, MSc, FRCPC: Minimal Systemic Exposure of Delgocitinib Cream in Chronic Hand Eczema
Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies
Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies
Key Considerations for Evaluating Ruxolitinib Cream as a Treatment for Young Children
Key Considerations for Evaluating Ruxolitinib Cream as a Treatment for Young Children
Supporting Caregivers in Successful Long-Term Atopic Dermatitis Management: The Role of Dermatologists
Supporting Caregivers in Successful Long-Term Atopic Dermatitis Management: The Role of Dermatologists
Challenges and Emerging Solutions in Treatment for Age Groups: Addressing Disease Control, Safety, and Usability
Challenges and Emerging Solutions in Treatment for Age Groups: Addressing Disease Control, Safety, and Usability
Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma
Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma

All News

© 2025 MJH Life Sciences

All rights reserved.